Environmental risk factors for women with polycystic ovary syndrome in China: A population-based case-control study

Journal of Biological Regulators and Homeostatic Agents

Volumn 28, Issue 2, 2014, Pages 203-211

  Zhang, J ^a   Liu, X F ^a   Liu, Y ^a   Xu, Liangzhi ^a   Zhou, L L ^a   Tang, L L ^a   Zhuang, J ^a   Li, T T ^a   Guo, W Q ^a   Hu, R ^a   Qiu, D S ^a   Han, D W ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Endocrine disruptors; Environment; Polycystic ovary syndrome; Population based case control study; Risk factor

Indexed keywords

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHEMICAL INDUSTRY; CHILD; CHINA; COSMETICS; ENVIRONMENTAL EXPOSURE; FEMALE; FRUIT; GONADAL STEROID HORMONES; HUMANS; OCCUPATIONAL EXPOSURE; PESTICIDES; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; QUESTIONNAIRES; RISK FACTORS;

EID: 84905667726     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-36.
2. Shaw LJ, Bairey Merz CN, Azziz R, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008; 93:1276-84. (Pubitemid 351519721)
3. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998; 51:581-6. (Pubitemid 28376967)
4. Gambarin-Gelwan M, Kinkhabwala SV, Schiano TD, Bodian C, Yeh HC, Futterweit W. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol 2007; 5:496-501. (Pubitemid 46575354)
5. Diamanti-Kandarakis E, Christakou C, Marinakis E. Phenotypes and environmental factors: their influence in PCOS. Curr Pharm Des 2012; 18:270-82.
6. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine- disrupting chemicals: an endocrine society scientific statement. Endocr Rev 2009; 30:293-342.
7. Hickey TE, Legro RS, Norman RJ. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91:2789-91. (Pubitemid 44024652)
8. Junien C, Nathanielsz P. Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes. Obes Rev 2007; 8:487-502. (Pubitemid 47620722)
9. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41-7.
10. Kenji Y, Takashi Y, Masahiro S. Reliability and validity of a comprehensive environmental questionnaire for community-living elderly with healthcare needs. Psychogeriatrics 2008; 8:66-72.
11. Dumesic DA, Abbott DH, Padmanabhan V. Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord 2007; 8:127-41. (Pubitemid 47434646)
12. Hickey M, Slooda DM, Atkinson HC, Doherty DA, Franks S, Norman RJ, Newnham JP, Hart R. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab 2009; 94:3714-20.
13. Anderson H, Fogel N, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J Clin Endocrinol Metab 2010; 95:2180-6.
14. Fernandez M, Bianchi M, Lux-Lantos V, Libertun C. Neonatal exposure to bisphenol A alters reproductive parameters and gonadotropin releasing hormone signaling in female rats. Environ Health Perspect 2009; 117:757-62.
15. Takeuchi T, Tsutsumi O, Ikezuki Y, et al. Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity. Endocr J 2006; 53:485-91.
16. Zhou W, Liu J, Liao L, Han S, Liu J. Effect of bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells. Mol Cell Endocrinol 2008; 283:12-8.
17. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 2006; 114:106-12. (Pubitemid 43056876)
18. Alonso-Magdalena P, Laribi O, Ropero AB, Fuentes E, Ripoll C, Soria B, Nadal A. Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect 2005; 113:969-77. (Pubitemid 41149624)
19. Sakurai K, Kawazuma M, Adachi T, Harigaya T, Saito Y, Hashimoto N, Mori C. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 2004; 141:209-14. (Pubitemid 38250890)
20. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 2004; 51:165-9. (Pubitemid 38657551)
21. Tsutsumi O. Assessment of human contamination of estrogenic endocrine- disrupting chemicals and their risk for human reproduction. J Steroid Biochem Mol Biol 2005; 93:325-30. (Pubitemid 40602507)
22. Kandaraki E, Chatzigeorgiou A, Livadas S, et al. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab 2011; 96:E480-4.
23. Lovekamp-Swan T, Davis BJ. Mechanisms of phthalate ester toxicity in the female reproductive system. Environ Health Perspect 2003; 111:139-45. (Pubitemid 36305308)
24. Yamasaki K, Okuda H, Takeuchi T, Minobe Y. Effects of in utero through lactational exposure to dicyclohexyl phthalate and p,p′-DDE in Sprague-Dawley rats. Toxicol Lett 2009; 189:14-20.
25. de Zegher F, Ibáñez L. Early Origins of polycystic ovary syndrome: hypotheses may change without notice. J Clin Endocrinol Metab 2009; 94:3682-5.
26. Ibáñez L, López-Bermejo A, Callejo J, Torres A, Cabre S, Dunger D, de Zegher F. Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth. J Clin Endocrinol Metab 2008; 93:196-9.
27. Melo A, Vieira C, Barbieri M, et al. High prevalence of polycystic ovary syndrome in women born small for gestational age. Hum Reprod 2010; 25:2124-31.
28. Govarts E, Nieuwenhuijsen M, Schoeters G, et al OBELIX; ENRIECO. Birth weight and prenatal exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE): a metaanalysis within 12 European Birth Cohorts. Environ Health Perspect 2012; 120:162-70.
29. Colón I, Caro D, Bourdony CJ, Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect 2000; 108:895-900.
30. Ozen S, Darcan S, Bayindir P, Karasulu E, Simsek DG, Gurler T. Effects of pesticides used in agriculture on the development of precocious puberty. Environ Monit Assess 2012; 184:4223-32.
31. Hu X, Wang J, Dong W, Fang Q, Hu L, Liu C. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy. Epilepsy Res 2011; 97:73-82.